ibritumomab tiuxetan   

GtoPdb Ligand ID: 6777

Synonyms: IDEC-2B8 | IDEC-Y2B8-yttrium ibritumomab tiuxetan | NSC-715848 | Zevalin®
ibritumomab tiuxetan is an approved drug (FDA (2002), EMA (2004))
Compound class: Antibody
Comment: A monoclonal antibody used as a radioimmunotherapy treatment.
Classification
Compound class Antibody
Approved drug? Yes (FDA (2002), EMA (2004))
International Nonproprietary Names
INN number INN
7873 ibritumomab tiuxetan
Synonyms
IDEC-2B8 | IDEC-Y2B8-yttrium ibritumomab tiuxetan | NSC-715848 | Zevalin®
Comments
A monoclonal antibody used as a radioimmunotherapy treatment.
Database Links
Specialist databases
IMGT/mAb-DB 122
Other databases
GtoPdb PubChem SID 178103383
PubChem SID 178103383
Search PubMed clinical trials ibritumomab tiuxetan
Search PubMed titles ibritumomab tiuxetan
Search PubMed titles/abstracts ibritumomab tiuxetan
Wikipedia Ibritumomab_tiuxetan